| Primary |
| Hypothyroidism |
25.0% |
| Polyneuropathy |
25.0% |
| Product Used For Unknown Indication |
25.0% |
| Supplementation Therapy |
25.0% |
|
| Parkinson's Disease |
33.3% |
| Tachycardia |
33.3% |
| Tachypnoea |
33.3% |
|
| Secondary |
| Drug Abuse |
41.9% |
| Product Used For Unknown Indication |
41.9% |
| Hodgkin's Disease |
4.8% |
| Drug Use For Unknown Indication |
3.7% |
| Psychotic Disorder |
1.5% |
| Breast Cancer |
0.7% |
| Depression |
0.7% |
| Hypertension |
0.7% |
| Schizoaffective Disorder |
0.7% |
| Anticoagulant Therapy |
0.4% |
| Colony Stimulating Factor Therapy |
0.4% |
| Dysphonia |
0.4% |
| Gastrooesophageal Reflux Disease |
0.4% |
| Hypothyroidism |
0.4% |
| Pain |
0.4% |
| Prophylaxis Against Gastrointestinal Ulcer |
0.4% |
| Schizophrenia |
0.4% |
| Thyroxine Decreased |
0.4% |
|
| Type 2 Diabetes Mellitus |
18.2% |
| Delirium |
9.1% |
| Electrocardiogram Qt Prolonged |
9.1% |
| Hyponatraemia |
9.1% |
| Peripheral Sensory Neuropathy |
9.1% |
| Speech Disorder |
9.1% |
| Surgery |
9.1% |
| Tremor |
9.1% |
| Vascular Occlusion |
9.1% |
| Ventricular Septal Defect |
9.1% |
|
| Concomitant |
| Drug Use For Unknown Indication |
16.9% |
| Hypothyroidism |
12.7% |
| Product Used For Unknown Indication |
12.0% |
| Hypertension |
9.4% |
| Rheumatoid Arthritis |
7.7% |
| Epilepsy |
4.3% |
| Depression |
4.2% |
| Osteoporosis |
4.2% |
| Pain |
3.9% |
| Asthma |
3.1% |
| Diabetes Mellitus |
3.1% |
| Prophylaxis |
2.5% |
| Chronic Obstructive Pulmonary Disease |
2.3% |
| Atrial Fibrillation |
2.2% |
| Breast Cancer |
2.2% |
| Constipation |
2.1% |
| Type 2 Diabetes Mellitus |
2.1% |
| Nausea |
1.9% |
| Thyroid Disorder |
1.6% |
| Blood Pressure |
1.5% |
|
| Weight Decreased |
8.8% |
| Pneumonia |
8.2% |
| Vomiting |
8.2% |
| Pyrexia |
7.0% |
| Weight Increased |
7.0% |
| Somnolence |
6.4% |
| Syncope |
5.3% |
| Oedema Peripheral |
4.7% |
| Pelvic Mass |
4.7% |
| Respiratory Failure |
4.7% |
| Urticaria |
4.7% |
| Spina Bifida |
4.1% |
| Tendonitis |
4.1% |
| Hypothyroidism |
3.5% |
| Transient Ischaemic Attack |
3.5% |
| Vasculitis |
3.5% |
| Adrenocortical Insufficiency Acute |
2.9% |
| Death |
2.9% |
| Premature Baby |
2.9% |
| Progressive Multifocal Leukoencephalopathy |
2.9% |
|
| Interacting |
| Blood Thyroid Stimulating Hormone Increased |
20.0% |
| Chronic Myeloid Leukaemia |
20.0% |
| Dysphonia |
20.0% |
| Gastrooesophageal Reflux Disease |
20.0% |
| Hypothyroidism |
20.0% |
|
| Hypotension |
33.3% |
| International Normalised Ratio Increased |
33.3% |
| Vision Blurred |
33.3% |
|
